An anticonvulsant pharmaceutical composition which comprises an anticonvulsive effective amount of a compound of the formula ##STR8## wherein R.sub.1 is hydrogen, loweralkyl, aryl, arylloweralkyl, loweralkenyl or loweralkynyl;
- the term "aryl" means phenyl, unsubstituted or substituted with halogen, loweralkyl, loweralkoxy, CF, NO.sub.2 or OH;
- R.sub.2 and R.sub.3 together form a spiro-fused cycloalkane ring of 4 to 6 carbons;
- X and Y are independently hydrogen, halogen, hydroxy, loweralkoxy, nitro, amino or trifluoromethyl;
- m and n are independently integers of 1 to 3, or a pharmaceutically acceptable acid addition salt thereof, or, where applicable, an optical, geometrical or stereoisomer or racemic mixture thereof and a suitable carrier therefor.